期刊文献+

降钙素原在外科感染性疾病中的临床应用价值 被引量:1

Clinical application value of procalcitonin in surgical infectious diseases
下载PDF
导出
摘要 目的探讨降钙素原(PCT)在外科感染性疾病中的临床应用价值。方法 65例外科手术患者,根据出院诊断将其分为脓毒血症组(15例)、局部感染组(27例)、非感染对照组(23例)。比较入院当天的PCT差异。结果脓毒血症组及局部感染组PCT浓度[(15.62±12.17)、(4.39±3.52)ng/ml]均高于非感染对照组(0.45±0.16)ng/ml,差异均有统计学意义(P<0.05);脓毒血症组高于局部感染组(P<0.05)。结论 PCT可作为外科判断是否存在细菌感染及感染严重程度的可靠指标,并对合理使用抗生素有重要的参考价值。 Objective To investigate clinical application value of procalcitonin(PCT) in surgical infectious diseases. Methods A total of 65 patients, who received surgical operation, were divided by their discharge diagnosis into septicopyemia group(15 cases), local infection group(27 cases) and non-infection control group(23 cases). Comparison was made on difference of PCT between the groups. Results The septicopyemia group had the local infection group had all higher PCT concentration[(15.62±12.17) and(4.39±3.52) ng/ml]than(0.45±0.16) ng/ml in the non-infection control group. Their differences all had statistical significance(P〈0.05). The septicopyemia group also had higher concentration than the local infection group(P〈0.05). Conclusion As a creditable indicator, PCT can be taken in diagnosis of surgical bacterial infection and infection severity. It also contains important reference value for rational antibiotics use.
作者 沙永涛
出处 《中国实用医药》 2016年第24期3-5,共3页 China Practical Medicine
关键词 降钙素原 外科 感染 Procalcitonin Surgery Infection
  • 相关文献

参考文献12

  • 1Zahedpasha Y, Ahmadpourkacho M, Hajiahmadi M, et al. Procal- citonin as a marker of neonatal sepsis. Iranian Journal of Pediatrics, 2009, 19(2):117-122.
  • 2陆一鸣.降钙素原PCT感染诊治新技术[J].国际检验医学杂志,2013,34(20):2641-2642. 被引量:29
  • 3Schneider HG, Lam QT. Procalcitonin for the clinical laboratory: a review. Pathology, 2007, 39(4):383-390.
  • 4崔庆,徐延景,张建勇.普外科手术感染患者血清中降钙素原及C-反应蛋白检测的临床意义[J].中华医院感染学杂志,2011,21(15):3181-3182. 被引量:18
  • 5Reinhart K, Meisner M, Brunkhorst FM. Markers for sepsis diagnosis: what is useful? Crit Care Clin, 2006, 22(3):503-519.
  • 6何礼贤.降钙素原指导严重细菌感染和脓毒血症诊疗的临床意义[J].中华结核和呼吸杂志,2012,35(8):636-637. 被引量:33
  • 7Leli C, Cardaccia A, Ferranti M, et al. Procalcitonin better than C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in predicting DNAemia in patients with sepsis. Scand J Infect Dis, 2014, 46(11):745-752.
  • 8Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet, 1993, 341(8844):515-518.
  • 9王智慧,祝啸先.降钙素原临床研究进展[J].疾病监测与控制,2013,7(11):680-683. 被引量:18
  • 10Karlsson S, Heikkinen M, Pettil~i V, et al. Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Critical Care, 2010, 14(6):1-10.

二级参考文献40

  • 1胡如雪.降钙素原(PCT)的临床应用价值[J].江西医学检验,2005,23(3):259-259. 被引量:39
  • 2中华人民共和国卫生部,医院感染诊断标准[s].北京:中华人民共和国卫生部,2001.
  • 3王爱,周炯,马小军,董俐俐,李桂萍.胰腺外科手术部位感染与围手术期抗菌药物应用[J].中国医学科学院学报,2007,29(4):566-570. 被引量:6
  • 4汪芸,李尔珍.降钙素原在临床的应用研究进展[J].实用儿科临床杂志,2007,22(18):1427-1429. 被引量:18
  • 5Christ-Crain M, Miiller B. Procalcitonin in bacterial infections- hype, hope, more or less? Swiss Med Wkly, 2005,135:451-460.
  • 6Meisner M. Procalcitonin--a new marker of severe infection and sepsis. New York:Thleme,2000.
  • 7Lapichino G, Marzorati S, Umbrello M, et al. Daily monitoring of biomarkers of sepsis in complicated long-term ICU-patients can it support treatment decisions? . Minerva Anestesiol,2010,76 : 814- 823.
  • 8Brunkhorst FM, Herinz U, Foryck ZF. Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med, 1998,24:888-889.
  • 9Schuetz P, Albrich W, Christ-Crain M, et al. Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther,2010, 8:575-587.
  • 10Meisner M, Tschaikowsky K, Palmaers T, et al. Comparison of procaleitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care,1999, 3: 45-50.

共引文献97

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部